Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
NCT ID: NCT01273935
Last Updated: 2011-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2010-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731
Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.
NCT01375400
Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
NCT00123305
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
NCT04504864
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Responder
Responder versus Non-Responder as a result of platelet function test
No interventions assigned to this group
Non-Responder
According to the result of platelet function test
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dekanat der Medizinischen Fakultät, Forschungsreferat - FoRUM
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saskia H Meves, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Neurology, St. Josef - Hospital, Bochum, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, St. Josef - Hospital, Ruhr-University
Bochum, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MevesASS01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.